These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36989345)

  • 21. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
    Han S; Guo J; Liu Y; Zhang Z; He Q; Li P; Zhang M; Sun H; Li R; Li Y; Zeng W; Liu J; Lian L; Gao Y; Shen L
    Oncotarget; 2015 Dec; 6(42):44452-65. PubMed ID: 26540347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein.
    Ikushima H; Todo T; Ino Y; Takahashi M; Saito N; Miyazawa K; Miyazono K
    J Biol Chem; 2011 Dec; 286(48):41434-41441. PubMed ID: 21987575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical cancer cells with positive Sox2 expression exhibit the properties of cancer stem cells.
    Liu XF; Yang WT; Xu R; Liu JT; Zheng PS
    PLoS One; 2014; 9(1):e87092. PubMed ID: 24489842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis.
    Pastushenko I; Mauri F; Song Y; de Cock F; Meeusen B; Swedlund B; Impens F; Van Haver D; Opitz M; Thery M; Bareche Y; Lapouge G; Vermeersch M; Van Eycke YR; Balsat C; Decaestecker C; Sokolow Y; Hassid S; Perez-Bustillo A; Agreda-Moreno B; Rios-Buceta L; Jaen P; Redondo P; Sieira-Gil R; Millan-Cayetano JF; Sanmatrtin O; D'Haene N; Moers V; Rozzi M; Blondeau J; Lemaire S; Scozzaro S; Janssens V; De Troya M; Dubois C; Pérez-Morga D; Salmon I; Sotiriou C; Helmbacher F; Blanpain C
    Nature; 2021 Jan; 589(7842):448-455. PubMed ID: 33328637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SIX2 Mediates Late-Stage Metastasis via Direct Regulation of
    Oliphant MUJ; Vincent MY; Galbraith MD; Pandey A; Zaberezhnyy V; Rudra P; Johnson KR; Costello JC; Ghosh D; DeGregori J; Espinosa JM; Ford HL
    Cancer Res; 2019 Feb; 79(4):720-734. PubMed ID: 30606720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
    Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
    Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
    Wang Z; Tan M; Chen G; Li Z; Lu X
    IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SOX2 Promotes Radioresistance in Non-small Cell Lung Cancer by Regulating Tumor Cells Dedifferentiation.
    Wang S; Li Z; Li P; Li L; Liu Y; Feng Y; Li R; Xia S
    Int J Med Sci; 2023; 20(6):781-796. PubMed ID: 37213675
    [No Abstract]   [Full Text] [Related]  

  • 29. Cancer IgG, a potential prognostic marker, promotes colorectal cancer progression.
    Jiang H; Kang B; Huang X; Yan Y; Wang S; Ye Y; Shen Z
    Chin J Cancer Res; 2019 Jun; 31(3):499-510. PubMed ID: 31354219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MELK inhibition targets cancer stem cells through downregulation of SOX2 expression in head and neck cancer cells.
    Ren L; Deng B; Saloura V; Park JH; Nakamura Y
    Oncol Rep; 2019 Apr; 41(4):2540-2548. PubMed ID: 30720113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
    Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
    Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
    Chen S; Giannakou A; Wyman S; Gruzas J; Golas J; Zhong W; Loreth C; Sridharan L; Yamin TT; Damelin M; Geles KG
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11671-E11680. PubMed ID: 30487219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity.
    Nakatsugawa M; Takahashi A; Hirohashi Y; Torigoe T; Inoda S; Murase M; Asanuma H; Tamura Y; Morita R; Michifuri Y; Kondo T; Hasegawa T; Takahashi H; Sato N
    Lab Invest; 2011 Dec; 91(12):1796-804. PubMed ID: 21931300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOX2 in cancer stemness: tumor malignancy and therapeutic potentials.
    Mamun MA; Mannoor K; Cao J; Qadri F; Song X
    J Mol Cell Biol; 2020 Feb; 12(2):85-98. PubMed ID: 30517668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells.
    Basu-Roy U; Bayin NS; Rattanakorn K; Han E; Placantonakis DG; Mansukhani A; Basilico C
    Nat Commun; 2015 Apr; 6():6411. PubMed ID: 25832504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
    Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
    Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOX2-associated signaling pathways regulate biological phenotypes of cancers.
    Ding LN; Yu YY; Ma CJ; Lei CJ; Zhang HB
    Biomed Pharmacother; 2023 Apr; 160():114336. PubMed ID: 36738502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells.
    Jung K; Wu F; Wang P; Ye X; Abdulkarim BS; Lai R
    BMC Cancer; 2014 May; 14():328. PubMed ID: 24885403
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Das B; Pal B; Bhuyan R; Li H; Sarma A; Gayan S; Talukdar J; Sandhya S; Bhuyan S; Gogoi G; Gouw AM; Baishya D; Gotlib JR; Kataki AC; Felsher DW
    Cancer Res; 2019 Aug; 79(16):4015-4025. PubMed ID: 31266772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.